The ability to generate quality information is the one factor in an IT system that can improve medical care, tackle supplier integration, and convince physicians to buy into the use of IT, according to a triumvirate of experts presenting at HIMSS09. But while quality information is the obvious goal of healthcare IT, the means for achieving it is anything but.
The ability to generate quality information is the one factor in an IT system that can improve medical care, tackle supplier integration, and convince physicians to buy into the use of IT, according to a triumvirate of experts presenting at HIMSS09. But while quality information is the obvious goal of healthcare IT, the means for achieving it is anything but.
Specifically at issue is the technology for determining what is “quality information.” Only by developing and implementing effective means to measure this quality can the operators of healthcare IT have a means for assessing the IT itself.
Dr. David Reiter of Jefferson Medical College and Dr. Eugene S. Schneller of Arizona State University joined with Randy L. Thomas, vice president of Integrated Product Management and Marketing at Premier, to argue that value analysis techniques can be harnessed to ensure quality information. Any of several metrics might be applied. The one common denominator is the end result, specifically the output of reliable and applicable data.
Winning physician “buy-in” to healthcare IT is a major reason behind the effort to develop these metrics and the quality information they breed, the presenters said. Quality information empowers physicians by identifying opportunities for improved care. There are other benefits as well, specifically that quality information can be used to improve the integration of suppliers, as it indicates where and how suppliers can work more effectively.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.